The downregulation of peptidoglycan recognition protein 2, a liver-specific pattern-recognition receptor, in HCC has been involved in poor prognosis, while its overexpression in HCC cells enhanced anti-tumor immune responses in mice (Yang et al., 2020). This evidence concerns the gene PGLYRP2 and hepatocellular carcinoma.